Cargando…
Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data
Antibodies targeting the PD-1, PD-L1, and CTLA-4 immune checkpoint axis have been used in a variety of tumor types. They achieve anti-tumor activity through activating the patient’s own immune system to target immune response evading cancer cells. However, this unique mechanism of action may cause i...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405813/ https://www.ncbi.nlm.nih.gov/pubmed/34462476 http://dx.doi.org/10.1038/s41598-021-96467-5 |